Back to Patient Square Capital LP
Q3 2026 13F filing
Updated 12 days ago23 disclosed positions worth $626.7M
Portfolio value
$626.7M
Total holdings
23
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-10
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R ROIVANT SCIENCES LTD | $282M | 7.71M | 45.00% | — |
| 2 | R REVOLUTION MEDICINES INC | $40.2M | 196.0K | 6.42% | — |
| 3 | U UNITED THERAPEUTICS CORP DEL | $34M | 62.7K | 5.42% | — |
| 4 | A ARGENX SE | $26.8M | 28.0K | 4.28% | — |
| 5 | P PHARVARIS N V | $25.7M | 808.6K | 4.09% | — |
| 6 | A ABIVAX SA | $24.1M | 243.0K | 3.84% | — |
| 7 | B BELITE BIO INC | $22.4M | 131.7K | 3.57% | — |
| 8 | M MIRUM PHARMACEUTICALS INC | $20M | 234.0K | 3.19% | — |
| 9 | Z ZAI LAB LTD | $15.6M | 591.5K | 2.49% | — |
| 10 | D DEFINIUM THERAPEUTICS INC | $14.7M | 385.0K | 2.34% | — |
| 11 | C COMPASS PATHWAYS PLC | $13.1M | 1.06M | 2.10% | — |
| 12 | D DBV TECHNOLOGIES S A | $13M | 1.11M | 2.07% | — |
| 13 | B BEONE MEDICINES LTD | $12.3M | 33.5K | 1.96% | — |
| 14 | C COGENT BIOSCIENCES INC | $11.6M | 361.9K | 1.85% | — |
| 15 | R ARCUS BIOSCIENCES INC | $10.6M | 410.0K | 1.69% | — |
| 16 | B BIONTECH SE | $10.4M | 105.4K | 1.65% | — |
| 17 | E ENLIVEN THERAPEUTICS INC | $9.7M | 212.5K | 1.55% | — |
| 18 | P VAXCYTE INC | $9.4M | 166.0K | 1.51% | — |
| 19 | K KYMERA THERAPEUTICS INC | $9.4M | 84.0K | 1.50% | — |
| 20 | A ALLOGENE THERAPEUTICS INC | $7.3M | 4.55M | 1.16% | — |
| 21 | ? N/A ZENTALIS PHARMACEUTICALS INC | $5.6M | 2.01M | 0.89% | — |
| 22 | I INVENTIVA SA | $4.5M | 1.22M | 0.72% | — |
| 23 | H HARROW INC | $4.5M | 145.0K | 0.71% | — |